Genetic manipulation of mammary gland development and lactation

Advances in Experimental Medicine and Biology

Volumn 554, Issue , 2004, Pages 229-251

  Hadsell, Darryl L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 2;

APOPTOSIS; BREAST DEVELOPMENT; BREAST DUCT; CELL CYCLE; CONFERENCE PAPER; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC ENGINEERING; GENETIC MANIPULATION; GENETICALLY ENGINEERED MOUSE MODEL; LACTATION; MAMMARY GLAND; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

MAMMALIA; MUS MUSCULUS;

EID: 4644317858     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-4242-8_20     Document Type: Conference Paper

References (182)

1. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI, Westphal H. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 1996;12:106-109.
2. Ackler S, Ahmad S, Tobias C, Johnson MD, Glazer RI. Delayed mammary gland involution in mmtv-akt1 transgenic mice. Oncogene 2002;21:198-206.
3. Adam D. Draft cow genome heads the field. Nature 2002;417:778.
4. Andres AC, Schonenberger CA, Groner B, Hennighausen L, LeMeur M, Gerlinger P. Ha-ras oncogene expression directed by a milk protein gene promoter, tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proc Natl Acad Sci USA 1987;84:1299-1303.
5. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B, Johnson RS, Kahn CR. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994;372:186-190.
6. Arranz JJ, Coppieters W, Berzi P, Cambisano N, Grisart B, Karim L, Marcq F, Moreau L, Mezer C, Riquet J, Simon P, Vanmanshoven P, Wagenaar D, Georges M. A QTL affecting milk yield and composition maps to bovine chromosome 20: a confirmation. Anim Genet 1998;29:107-115.
7. Baker J, Liu J-P, Robertson E, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1997;75:73-82.
8. Bates P, Fisher R, Ward A, Richardson L, Hill DJ, Graham CF. Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 1996;72:1189-1193.
9. Bendall AJ, Molloy PL. Base preferences for DNA binding by the bHLH-Zip protein USF: effects of MgCl2 on specificity and comparison with binding of Myc family members. Nucleic Acids Res 1994;22:2801-2810.
10. Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H. Sequence-specific DNA binding by the c-myc protein. Science 1990;250:1149-1151.
11. Bohula EA, Salisbury AJ, Sohail M, Playford MP, Riedemann J, Southern EM, Macaulay VM. The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript. J Biol Chem 2003;278:15991-15997.
12. Bonnette SG, Hadsell DL. Targeted disruption of the insulin-like growth factor I receptor gene inhibits cellular proliferation in mammary terminal endbuds (TEB). Endocrinology 2001;142:4937-4945.
13. Bremel RD, Yom HC, Bleck GT. Alteration of milk composition using molecular genetics. J Dairy Sci 1989:72:2826-2833.
14. Brinster RL, Chen HY, Messing A, Van Dyke T, Levine AJ, Palmiter RD. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 1984;37:367-379.
15. Burks DJ, Font de Mora J, Schubert M, Withers DJ, Myers MG, Towery HH, Altamuro SL, Flint CL, White MF. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 2000;407:377-382.
16. Burrin DG, Fiorotto ML, Hadsell DL. Transgenic hypersecretion of des(1-3)human insulin-like growth factor I in mouse milk has limited effects on the gastrointestinal tract in suckling pups. J Nutr 1999;129;51-56.
17. Butte NF, Garza C, Smith EO, Nichols BL. Human milk intake and growth in exclusively breast-fed infants. J Pediatr 1984;104:187-195.
18. Byme GW, Ruddle FH. Multiplex gene regulation: a two-tiered approach to transgene regulation in transgenic mice. Proc Natl Acad Sci USA 1989;86:5473-5477.
19. Capuco AV, Kahl S, Jack LJ, Bishop JO, Wallace H. Prolactin and growth hormone stimulation of lactation in mice requires thyroid hormones. Proc Soc Exp Biol Med 1999;221:345-351.
20. Carmell MA, Zhang L, Conklin D, Hannon GJ, Rosenquist TA. Germline transmission of RNAi in mice. Nat Struct Biol 2003;10:91-92.
21. Chapman RS, Lourenco P, Tonner E, Flint D, Selbert S, Takeda K, Akira S, Clarke AR, Watson CJ. The role of StatS in apoptosis and mammary gland involution. Conditional deletion of StatS. Adv Exp Med Biol 2000;480:129-138.
22. Clark AJ. The mammary gland as a bioreactor: expression processing, and production of recombinant proteins J Mammary Gland Biol Neoplasia 1998;3:337-350.
23. Clemmons DR, Dehoff MH, Busby WH, Bayne ML, Cascieri MA. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by IGFs and IGF analogs. Endocrinology 1992;131:890-895.
24. Covarrubias L, Nishida Y, Mintz B. Early postimplantation embryo lethality due to DNA rearrangements in a transgenic mouse strain. Proc Natl Acad Sci USA 1986;83:6020-6024.
25. Cox DB, Owens RA, Harrmann PE. Blood and milk prolactin and the rate of milk synthesis in women. Exp Physiol 1996;81:1007-1020.
26. Cunha GR, Young P, Horn YK, Cooke PS, Taylor JA, Lubahn DB. Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants. J Mammary Gland Biol Neoplasia 1997;2:393-402.
27. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001;29:229-232.
28. DeOme KB, Faulkin LJ Jr, Bern HA, Blair PE. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 1959;19:515-520.
29. Dulak N, Temin HM. A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication stimulating activity for embryo fibroblasts. J Cell Physiol 1972;81:153-160.
30. Dunbar ME, Dann P, Brown CW, Van Houton J, Dreyer B, Philbrick WP, Wysolmerski JJ. Temporally regulated overexpression of parathyroid hormone-related protein in the mammary gland reveals distinct fetal and pubertal phenotypes. J Endocrinol 2001;171:403-416.
31. Dymecki SM. F1p recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. Proc Natl Acad Sci USA 2003:93:6191-6196.
32. Edwards PAW, Ward JL, Bradbury JM. Alteration of morphogenesis by the v-myc oncogene in transplants of mammary gland. Oncogene 1988;2:407-412.
33. El Mkadem SA, Lautier C, Macari F, Molinari N, Lefebvre P, Renard E, Gris JC, Gros G, Daurès JP, Bringer J, White MF, Grigorescu F. Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes 2001;50:2164-2168.
34. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-498.
35. Epstein-Baak R, Lin Y, Bradshaw V, Cohn M. Inducible transformation of cells from transgenic mice expressing SV40 under lac operon control. Cell Growth Differ 1992;3:127-134.
36. Fantin VR, Wang Q, Lienhard GE, Keller SR. Mice lacking insulin receptor substrate 4 exhibit mild defects in growth reproduction and glucose homeostasis. Am J Physiol Endocrinol Metab 2001;278:E127-E133.
37. Farrelly N, Lee YJ, Oliver J, Dive C, Streuli CH. Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol 1999;144:1337-1348.
38. Flint DJ, Tonner E, Allan GJ. Insulin-like growth factor binding proteins:IGF-dependent and -independent effects in the mammary gland. J Mammary Gland Biol Neoplasia 2000;5:65-73.
39. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 1994;91:9302-9306.
40. Gillespie C, Read LC, Bagley CJ, Ballard FJ. Enhanced potency of truncated insulin-like growth factor-1 (des(1-3)IGF-I) relative to IGF-I in lit/lit mice. J Endocrinol 1990;127:401-405.
41. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH. Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA 1980;77:7380-7384.
42. Gossen M, Bujard H. Studying gene function in eukaryotes by conditional gene inactivation. Annu Rev Genet 2002;36:153-173.
43. Grandori C, Cowley SM, James LP, Eisenman RN. The myc/max/mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2001;16 653-699.
44. Gregor PD, Sawadogo M, Roeder RG. The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev 1990;4:1730-1740.
45. Grisart B, Coppieters W, Farnir F, Karim L, Ford C, Berzi P, Cambisano N, Mni M, Reid S, Simon P, Spelman R, Georges M, Snell R. Positional candidate cloning of a QTL in dairy cattle: identification of a missense mutation in the bovine DGAT1 gene with major effect on milk yield and composition. Genome Res 2002;12:222-231.
46. Gutierrez A, Meade HM, Ditullio P, Pollock D, Harvey M, Jimenez-Flores R, Anderson GB, Murray JD, Medrano JF. Expression of a bovine kappa-CN cDNA in the mammary gland of transgenic mice utilizing a genomic milk protein gene as an expression cassette. Transgenic Res 1996;5:271-279.
47. Gutierrez-Adan A, Maga EA, Meade HM, Shoemaker CF, Medrano JF, Anderson GB, Murray JD. Alterations of the physical characteristics of milk from transgenic mice producing bovine k-casein. J Dairy Sci 1996;79:791-799.
48. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992;12:954-961.
49. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ. Activation of the c-src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 1996;8:23-32.
50. Hadsell D, Greenberg NM, Fligger JM, Baumrucker CM, Rosen JM. Targeted expression of des (1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology 1996;137:321-330.
51. Hadsell DL, Bonnette SG. IGF and insulin action in the mammary gland: lessons from transgenic and knockout models. J Mammary Gland Biol Neoplasia 2000;5:19-30.
52. Hadsell DL, Murphy KL, Reece N, Alexeenko T, Lascerica R, Rosen JM. Cooperation between des(1-3)IGF-I and mutant p53 accelerates mammary gland carcinogenesis in bigenic mice. Oncogene 2000;19:889-898.
53. Hadsell DL, Alexeenko T, Klemintidis Y, Torres D, Lee AV. Inability of overexpressed des(1-3)human insulin-like growth factor I (IGF-I) to inhibit forced mammary gland involution is associated with decreased expression of IGF signaling molecules. Endocrinology 2001;142:1479-1488.
54. Hadsell DL, Bonnette SG, Lee AV. Genetic manipulation of the IGF-I axis to regulate mammary gland development and function. J Dairy Sci 2002;85:365-377.
55. Hansen LB. Consequences of selection for milk yield from a geneticist's viewpoint. J Dairy Sci 2000;83:1145-1150.
56. Hennighausen L, Wall RJ, Tillmann U, Li M, Furth PA. Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system. J Cell Biochem 1995;59:463-472.
57. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR, Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 1989;77:61-68.
58. Houdebine LM. Transgenic animals as bioreactors. Transgenic Res 2000;9:305-320.
59. Hovey RC, Harris J, Hadsell DL, Lee AV, Ormandy CJ, Vonderhaar BK. Local insulin-like growth factor-II mediates PRL-induced mammary gland development. Mol Endocrinol 2002;17:460-471.
60. Hsu SY, Nakabayashi K, Nishi S, Kumagi J, Kudo M, Sherwood OD, Hsueh AJW. Activation of orphan receptors by the hormone relaxin. Science 2002;295:671-674.
61. Humphreys RC, Lydon J, O'Malley BW, Rosen JM. Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol Endocrinol 1997;11:801-811.
62. Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 2001;21;2203-2212.
63. Iavnilovitch E, Groner B, Barash I. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis. Mol Cancer Res 2002;1;32-47.
64. Ivell R, Bathgate RAD. Reproductive biology of the relaxin-like growth factor (RFL/INSL3). Biology Reprod 2002;67:699-705.
65. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, Todd JA. Haplotype tagging for the identification of common disease genes. Nat Genet 2001;29:233-237.
66. Johnson MS, Thomson SC, Speakman JR. Limits to sustained energy intake. I. lactation in the laboratory mouse Mus musculus. J Exp Biol 2001;204:1925-1935.
67. Keiper BD, Can W, Rhoads RE. Protein synthesis initiation factor 4G. Int J Biochem Cell Biol 1999;31:37-41.
68. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF, Accili D. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1 and IRS-2. J Clin Invest 2000;105:199-205.
69. Kleinberg DL, Ruan W, Catanese V, Newman CB, Feldman M. Non-lactogenic effects of growth hormone on growth and insulin-like growth factor-I messenger ribonucleic acid of rat mammary gland [published erratum appears in Endocrinology 1990 Oct;127(4):1977]. Endocrinology 1990;126:3274-3276.
70. Kleinberg DL, Ruan W, Catanese V, Newman CB, Feldman M. Non-lactogenic effects of growth hormone on growth and insulin-like growth factor-I messenger ribonucleic acid of rat mammary gland [published erratum appears in Endocrinology 1990 Oct;127(4):1977]. Endocrinology 1990;126:3274-3276.
71. Kleinberg DL, Feldman M, Ruan W. IGF-I: An essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia 2000;5:7-18.
72. Korach KS. Insights from the study of animal lacking functional estrogen receptor. Science 1994;266:1524-1527.
73. Kubota N, Tobe K, Terauchi Y, Kazuhiro E, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, Satoh S, Sekihara H, Sciacchitano S, Lesniak M, Aizawa S, Nagai R, Kimura S, Akanuma Y, Taylor SI, Kadowaki T. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia. Diabetes 2000;49:1880-1889.
74. Kunath T, Gish G, Lickert H, Jones N, Pawson T, Rossant J. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nature Biotechnol 2003;21:559-561.
75. L'Huillier PJ, Soulier S, Stinnakre MG, Lepourry L, Davis SR, Mercier JC, Vilotte JL. Efficient and specific ribozyme-mediated reduction of bovine alpha-lactalbumin expression in double transgenic mice. Proc Natl Acad Sci USA 1996;93:6698-6703.
76. Lacy E, Costantini FD. Structure and expression of foreign globin genes in transgenic mice. Prog Clin Biol Res 1983;134:13-25.
77. Lacy E, Roberts S, Evans EP, Burtenshaw MD, Costantini FD. A foreign beta-globin gene in transgenic mice: integration at abnormal chromosomal positions and expression in inappropriate tissues. Cell 1983;34:343-358.
78. Lakso M, Sauer B, Mosinger B Jr, Lee EJ, Manning RW, Yu S-H, Mulder KL, Westphal H. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 1992;89:6232-6236.
79. -/. double knockout mice. Genes Dev 2002;16:3213-3222.
80. Le Fur S, Le Stunff C, Bougnères P. Increased insulin resistance in obese children who have both 972 IRS-1 and 1057 IRS-2 polymorphisms. Diabetes 2002;51:S304-S307.
81. Le Provost F, Riedlinger G, Hee YS, Benedict J, Gonzalez FJ, Flaws J, Hennighausen L. The aryl hydrocarbon receptor (AhR) and its nuclear translocator (Arnt) are dispensable for normal mammary gland I. development but are required for fertility. Genesis 2002;32;231-239.
82. Lee KF, DeMayo FJ, Atiee SH, Rosen JM. Tissue-specific expression of the rat β-casein gene in transgenic mice. Nucleic Acids Res 1988;16:1027-1041.
83. Lee AV, Zhang P, Ivanova M, Bonnette S, Oesterreich S, Rosen JM, Grimm S, Hovey RC, Vonderhaar BK, Kahn CR, Torres D, George J, Mohsin S, Allred DC, Hadsell DL. Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland. Endocrinology 2003;144:2683-2694.
84. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002;32:107-108.
85. Li M, Liu X, Robinson G, Bar-Peled U, Wagner K, Young WS, Hennighausen L, Furth PA. Mammary-derived signals activate programmed cell dath during the first stage of mammary gland involution. Proc Natl Acad Sci USA 1997;94:3425-3430.
86. Lin TP, Guzman RC, Osborn RC, Thordarson G, Nandi S. Role of endocrine, autocrine and paracrine interactions in the development of mammary hyperplasia in wnt-1 transgenic mice. Cancer Res 1992;56:4413-4419.
87. Liu SC, Wang Q, Lienhard GE, Keller SR. Insulin receptor substrate 3 is not essential for growth or glucose homeostasis. J Biol Chem 1999;274:18093-18099.
88. Lok S, Johnston DS, Conklin D, Lofton-Day CE, Adams RL, Jelmberg AC, Whitmore TE, Schrader S, Griswold MD, Jaspers SR. Identification of INSL6, a new member of the insulin family that is expressed in the testis of the human and rat. Biol Reprod 2000;62:1593-1599.
89. Lufkin T, Dierich A, LeMeur M, Mark M, Chambon P. Disruption of the Hox-1.6 homeobox gene results in defects in a region corresponding to its rostral domain of expression. Cell 1991;66:1105-1119.
90. Lyons WR, Li CH, Johnson RE. The hormonal control of mammary growth and lactation. Recent Prog Horm Res 1958;4;219-248.
91. Madon RJ, Ensor DM, Knight CH, Flint DJ. Effects of an antiserum to rat growth hormone on lactation in the rat. J Endocrinol 1986;111:117-123.
92. Manche L, Green SR, Schmedt C, Mathews MB. Interactions between double-stranded RNA regulators and the proteins kinase DAI. Mol Cell Biol 1992;12:5238-5248.
93. Marasco L, Marmet C, Shell E. Polycystic ovary syndrome: a connection to insufficient milk supply? J Hum Lact 2000;16:143-148.
94. Maroulakou IG, Anver M, Garrett L, Green JE. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc Natl Acad Sci USA 1994;91:11236-11240.
95. Marquardt H, Todaro GJ, Heriderson LE, Oroszlan S. Purification and primary structure of a polypeptide with multiplication-stimulating activity from rat liver cell cultures. J Biol Chem 1981;256:6859-6865.
96. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA. RNA interference in adult mice. Nature 2002;418:38-39.
97. McKendrick L, Pain VM, Morley SJ. Translation initiation factor 4E. Int J Biol Chem 1999;31:31-35.
98. Minks MA, West DK, Envin S, Aglioni C. Structural requirements of double-stranded RNA for the activations of 2′, 5′ -oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J Biol Chem 1979;254:10180-10183.
99. Moorehead RA, Fata JE, Johnson MB, Khokha R. Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice. Cell Death Differ 2001;8:16-29.
100. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988;1:105-115.
101. Murata H, Hresko RC, Mueckler M. Reconstitution of PI 3-kinasae-dependent insulin signaling in a cell-free system. J Biol Chem 2003;13:21607-21614.
102. Nagai J, Sarkar NK. Relationship between milk yield and mammary gland development in mice. J Dairy Sci 1978;61:733-739.
103. Nandi S. Endocrine control of mammary gland development and function in the C3 11/HE Crgl mouse. J Natl Cancer Inst 1958;21:1039-1062.
104. Neuenschwander S, Schwartz A, Wood TL, Roberts CTJ, Henninghausen L, LeRoith D. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest 1996;97:2225-2232.
105. Nguyen DA, Parlow AF, Neville MC. Hormonal regulation of tight junction closure in the mouse mammary epithelium during the transition from pregnancy to lactation. J Endocrinol 2001;170:347-356.
106. No D, Yao TP, Evans RM. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 1996;93:3346-3351.
107. Noble MS, Rodriguez-Zas S, Cook JB, Bleck GT, Hurley WL, Wheeler MB. Lactational performance of first-parity transgenic gilts expressing bovine alpha-lactalbumin in their milk. J Anim Sci 2002;80:1090-1096.
108. Oftedal OT. Milk composition, milk yield and energy output at peak lactation: a comparative review. Symp Zoolog Soc (London) 1984;51:33-85.
109. Ormandy CJ, Binart N, Kelly PA. Mammary gland development in prolactin receptor knockout mice. J Mammary Gland Biol Neoplasia 1997;2:355-364.
110. Ornitz DM, Moreadith RW, Leder P. Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements. Proc Natl Acad Sci USA 1991;88:698-702.
111. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002;16:948-958.
112. Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, Birnberg NC, Evans RM. Dramatic growth of mice that develop from eggs microinjected with metallothione in growth hormone fusion genes. Nature 1982;300:611-615.
113. Peel CJ, Bauman DE, Gorewit RC, Sniffen CJ. Effect of exogenous growth hormone on lactational performance in high yielding dairy cows. J Nutr 1981;111:1662-1671.
114. Peripato AC, de Brito RA, Vaughn TT, Pletscher LS, Matioli SR, Cheverud JM. Quantitative trait loci for maternal performance for offspring survival in mice. Genetics 2002;162:1341-1353.
115. Pittius CW, Hennighausen L, Lee E, Westphal H, Nicols E, Vitale J, Gordon K. A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice. Proc Natl Acad Sci USA 1988;85:5874-5878.
116. Plasterk RHA. RNA silencing: the genome's immune system. Science 2002;296:1263-1265.
117. Pravtcheva DD, Wise TL. Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice. J Exp Zool 1999;281:43-57.
118. Quarrie LH, Addey CV, Wilde CJ. Programmed cell death during mammary tissue involution induced by weaning, litter removal, and milk stasis. J Cell Physiol 1996;168:559-569.
119. Radice GL, Ferreira-Cornwell MC, Robinson SD, Rayburn H, Chodosh LA, Takeichi M, Hynes RO. Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol 1997;139:1025-1032.
120. Rinderknecht E, Humbel RE. Primary structure of human insulin-like growth factor II. FEBS Lett 1978a;89:283-286.
121. Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 1978b;253:2769-2776.
122. Robinson GW, Hennighausen L. Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development 1997;124:2701-2708.
123. Robinson GW, Accili D, Hennighausen L. Rescue of mammary epithelium of early lethal phenotypes by embryonic mammary gland transplantation as exemplified with insulin receptor null mice. In: Ip MM, Asch BB, editors. Methods in Mammary Gland Biology and Breast Cancer Research. New York: Kluwer Academic/Plenum Publishers, 2000; pp 307-316.
124. Roy AL, Carruthers C, Gutjahr T, Roeder RG. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature 1993;365:359-361.
125. Roy AL, Du H, Gregor PD, Novina CD, Martinez E, Roeder RG. Cloning of an Inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF-1. EMBO J 1997;16:7091-7104.
126. Ruan W, Kleinberg DL. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 1999;140:5075-5081.
127. Ruan W, Newman CB, Kleinberg DL. Intact and amino-terminally shortened forms of insulin-like growth; factor I induce mammary gland differentiation and development. Proc Natl Acad Sci USA 1992;89:10872-10876.
128. Ruan W, Catanese V, Wieczorek R, Feldman M, Kleinberg DL. Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid. Endocrinology 1995;136:1296-1302.
129. Ryan AS, Wenjun Z, Acosta A. Breastfeeding continues into the new millennium. Pediatrics 2002;110:1103-1109.
130. Salmon WD Jr, Daughaday WH. A hormonal controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 1957;49:825-826.
131. Sawadogo M. Multiple forms of the human gene-specific transcription factor USF. II. DNA binding properties and transcriptional activity of the purified HeLa USF. J Biol Chem 1988;263:11994-12001.
132. Sawadogo M, Roeder RG. Interaction of a gene-specific transcription factor with adenovirus major late promoter upstream of the TATA box region. Cell 1985;43:165-175.
133. Sawai S, Shimono A, Hanaoka K, Kondoh H. Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes. New Biol 1991;3:861-869.
134. Schaapveld RQ, Schepens JT, Robinson GW, Attema J, Oerlemans FT, Fransen JA, Streuli M, Wieringa B, Hennighausen L, Hendriks WJ. Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity. Dev Biol 1997;188:134-146.
135. Schwartzberg PL, Robertson EJ, Goff SP. Targeted gene disruption of the endogenous c-abl locus by homologous recombination with DNA encoding a selectable fusion protein. Proc Natl Acad Sci USA 1989;87:3210-3214.
136. Schwertfeger K, Richert MM, Anderson SM. Mammary gland involution is delayed by activated akt in transgenic mice. Mol Endocrinol 2001;15:867-881.
137. Schwertfeger KL, McManaman JL, Palmer CA, Neville MC, Anderson SM. Expression of constitutively activated Akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactation. J Lipid Res 2003;44:1100-1112.
138. Seagroves TN, Hadsell D, McManaman J, Palmer C, Liao D, McNulty W, Welm B, Wagner KU, Neville M, Johnson RS. HIF1alpha is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. Development 2003;130:1713-1724.
139. Selben S, Bentley DJ, Melton DW, Rannie D, Lourenco P, Watson CJ, Clarke AR. Efficient BLG-Cre mediated gene deletion in the mammary gland. Transgenic Res 1998;7:387-396.
140. Shinagawa T, Ishii S. Generation of Ski-knockdown mice by expressing a long double-strand RNA from an RNA polymerase II promoter. Genes Dev 2003;17:1340-1345.
141. Shipman LJ, Docherty AH, Knight CH, Wilde CJ. Metabolic adaptations in mouse mammary gland during a normal lactation cycle and in extended lactation. Q J Exp Physiol 1987;72:303-311.
142. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslma SZ, Bronson RT, Elledge SJ, Weinberg RA. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995;82:621-630.
143. Simons JP, McClenaghan M, Clark AJ. Alteration of the quality of milk by expression of sheep beta-lactoglobulin in transgenic mice. Nature 1987;328:530-532.
144. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 1987;49:465-475.
145. Sirito M, Lin Q, Maity T, Sawadogo M. Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res 1994;22:427-433.
146. Sirito M, Lin Q, Deng JM, Behringer RR, Sawadogo M. Overlapping roles and asymetrical cross-regulation of the USF proteins in mice. Proc Natl Acad Sci USA 1998;95:3758-3763.
147. Sohail M, Doran G, Riedemann J, Macaulay V, Southern EM. A simple and cost-effective method for producing small interfering RNAs with high efficacy. Nucleic Acids Res 2003;31:e38.
148. Soriano P, Gridley T, Jaenisch R. Retroviruses and insertional mutagenesis in mice: proviral integration at the Mov 34 locus leads to early embryonic death. Genes Dev 1987;1:366-375.
149. Soulier S, Stinnakre MG, Lepourry L, Mercier JC, Vilotte JL. Use of doxycycline-controlled gene expression to reversibly alter milk-protein composition in transgenic mice. Eur J Biochem 1999;260:533-539.
150. Stacey A, Bateman J, Choi T, Mascara T, Cole W, Jaenisch R. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene. Nature 1988;332:131-136.
151. Stacey A, Schnieke A, Kerr M, Scott A, McKee C, Cottingham I, Binas B, Wilde C, Colman A. Lactation is disrupted by alpha-lactalbumin deficiency and can be restored by human alpha-lactalbumin gene replacement in mice. Proc Natl Acad Sci USA 1995;92:2835-2839.
152. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998;67:227-264.
153. Stewart TA, Pattengale PK, Leder P. Spontaneous mammary adenocarcinomas in transgenic MTV/myc fusion genes. Cell 1984;38:627-637.
154. Stinnakre MG, Vilotte JL, Soulier S, Mercier JC. Creation and phenotypic analysis of alpha-lactalbumin-deficient mice. Proc Natl Acad Sci USA 1994;91:6544-6548.
155. Thomas KR, Capecchi MR. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987;51:503-512.
156. Thompson S, Clarke AR, Pow AM, Hooper ML, Melton DW. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell 1989;56:313-321.
157. Tonner E, Barber MC, Allan GJ, Beattie J, Webster J, Whitelaw CB, Flint DJ. Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development 2002;129:4547-4557.
158. Tsukamoto AS, Grosshedl R, Guzman RC, Parslow T, Varmus HE. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988;55:619-625.
159. Vallet VS, Henrion AA, Bucchini D, Casado M, Raymondjean M, Kahn A, Vaulont S. Glucose-dependent liver gene expression in upstream stimulatory factor 2 -/- mice. J Biol Chem 1997;272:21944-21949.
160. Vallet VS, Casado M, Henrion AA, Bucchini D, Raymondjean M, Kahn A, Vaulont S. Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose. J Biol Chem 1998;273:20175-20179.
161. van der Putten H, Botteri F, Illmensee K. Developmental fate of a human insulin gene in a transgenic mouse. Mol Gen Genet 1984;198:128-138.
162. VanWyk JJ, Hall K, Van den Brande JL, Weaver RP. Further purification and characterization of sulfation factor and thymidine factor from acromegalic plasma. J Clin Endocrinol Metab 1971;32:389-403.
163. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di F, V, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ,
164. Vilotte JL. Lowering the milk lactose in vivo: potential interests, strategies, and physiological consequences. Reprod Nutr Dev 2002;42:127-132.
165. Wagner KU, Wall RJ, St Onge L, Gross P, Wynshaw-Boris A, Garrett L, Li M, Furth PA, Hennighausen L. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 1997;25:4323-4330.
166. Wagner KU, McAllister K, Ward T, Davis B, Wiseman R, Hennighausen L. Spatial and temporal expression of the cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 2001;10:545-553.
167. Walton KD, Wagner KU, Rucker EB III, Shillingford JM, Miyoshi K, Hennighausen L. Conditional deletion of the bcl-x gene from mouse mammary epithelium results in accelerated apoptosis during involution but does not compromise cell function during lactation. Mech Dev 2001;109:281-293.
168. Wang Y, DeMayo FJ, Tsai SY, O'Malley BW. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat Biotechnol 1997;15:239-243.
169. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, Cawley S, Chiaromonte F, Chinwalla AT, Church DM, Clamp M, Clee C, Collins FS, Cook LL, Copley RR, Coulson A, Couronne O, Cuff J, Curwen V, Cutts T, Daly M, David R, Davies J, Delehaunty KD, Deri J, Dermitzakis ET, Dewey C, Dickens NJ, Diekhans M, Dodge S, Dubchak I, Dunn DM, Eddy SR, Elnitski L, Ernes RD, Eswara P, Eyras E, Felsenfeld A, Fewell GA, Flicek P, Foley K, Frankel WN, Fulton LA, Fulton RS, Furey TS, Gage D, Gibbs RA, Glusman G, Gnerre S, Goldman N, Goodstadt L, Grafham D, Graves TA, Green ED, Gregory S, Guigo R, Guyer M, Hardison RC, Haussler D, Hayashizaki Y, Hillier LW, Hinrichs A, Hlavina W, Holzer T, Hsu F, Hua A, Hubbard T, Hunt A, Jackson I, Jaffe DB, Johnson LS, Jones M, Jones TA, Joy A, Kamal M, Karlsson EK, Karolchik D, Kasprzyk A, Kawai J, Keibler E, Kells C, Kent WJ, Kirby A, Kolbe DL, Korf I, Kucherlapati RS, Kulbokas EJ, Kulp D, Landers T, Leger JP, Leonard S, Letunic I, Levine R, Li J, Li M, Lloyd C, Lucas S, Ma B, Maglott DR, Mardis ER, Matthews L, Mauceli E, Mayer JH, McCarthy M, McCombie WR, McLaren S, McLay K, McPherson JD, Meldrim J, Meredith B, Mesirov JP, Miller W, Miner TL, Mongin E, Montgomery KT, Morgan M, Mott R, Mullikin JC, Muzny DM, Nash WE, Nelson JO, Nhan MN, Nicol R, Ning Z, Nusbaum C, O'Connor MJ, Okazaki Y, Oliver K, Overton-Larty E, Pachter L, Parra G, Pepin KH, Peterson J, Pevzner P, Plumb R, Pohl CS, Poliakov A, Ponce TC, Ponting CP, Potter S, Quail M, Reymond A, Roe BA, Roskin KM, Rubin EM, Rust AG, Santos R, Sapojnikov V, Schultz B, Schultz J, Schwartz MS, Schwartz S, Scott C, Seaman S, Searle S, Sharpe T, Sheridan A, Shownkeen R, Sims S, Singer JB, Slater G, Smit A, Smith DR, Spencer B, Stabenau A, Stange-Thomann N, Sugnet C, Suyama M, Tesler G, Thompson J, Torrents D, Trevaskis E, Tromp J, Ucla C, Ureta-Vidal A, Vinson JP, Von Niederhausern AC, Wade CM, Wall M, Weber RJ, Weiss RB, Wendl MC, West AP, Wetterstrand K, Wheeler R, Whelan S, Wierzbowski J, Willey D, Williams S, Wilson RK, Winter E, Worley KC, Wyman, D, Yang S, Yang SP, Zdobnov EM, Zody MC, Lander ES. Initial sequencing and comparative analysis of the mouse genome. Nature 2002;420:520-562.
170. Wiltshire T, Pletcher MT, Batalov S, Barnes SW, Tarantino LM, Cooke MP, Wu H, Smylie K, Santrosyan A, Copeland NG, Jenkins NA, Kalush F, Mural RJ, Glynne RJ, Kay SA, Adams MD, Fletcher CF. Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse. Proc Natl Acad Sci USA 2003;100:3380-3385.
171. Wintermantel TM, Mayer AK, Schutz G, Greiner EF. Targeting mammary epithelial cells using a bacterial artificial chromosome. Genesis 2002;33:125-130.
172. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Wier S, White MF. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998;391:900-904.
173. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF. Irs-2 coordinates Igf-1 receptor-mediated β-cell development and perhipheral insulin signalling. Nat Genet 1999;23:32-40.
174. Wolf E, Jehle PM, Weber MM, Sauerwein H, Daxenberger A, Breier BH, Besenfelder U, Frenyo L, Brem G. Human insulin-like growth factor I (IGF-I) produced in the mammary glands of transgenic rabbits: yield, receptor binding, mitogenic activity, and effects on IGF-binding proteins. Endocrinology 1997;138:307-313.
175. Wood TL, Richert MM, Stull MA, Allar MA. The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands. J Mammary Gland Biol Neoplasia 2000;5:31-42.
176. Working Group on Breastfeeding. Breastfeeding and the use of human milk (RE9729). Pediatrics 1997;100:1035-1039.
177. Wysolmerski JJ, McCaughern-Carucci JF, Daifotis AG, Broadus AE, Philbrick WM. Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development 1995;121:3539-3547.
178. Xia H, Mao Q, Paulson HL, Davidson BL. siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 2002;20:1006-1010.
179. Yu SH, Deen KC, Lee E, Hennighausen L, Sweet RW, Rosenberg M, Westphal H. Functional human CD4 protein produced in milk of transgenic mice. Mol Biol Med 1989;6:255-261.
180. Yu J, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 2002;99:6047-6052.
181. Zamore PD. Ancient pathways programmed by small RNAs. Science 2002;296:1265-1269.
182. Zijlstra M, Li E, Sajjadi F, Subramani S, Jaenisch R. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 1989;342:435-438.